Recruiting
Rheumatoid arthritis+3
RecruitingInvestigationalNo placebo
Safety Study of CD19.CAR T Cells in Patients with Autoimmune‑Associated Severe Interstitial Lung Fibrosis
InvestigationalNo placebo
- Disease:Rheumatoid arthritisSystemic sclerosis pulmonary+2
- Substances:T Lymphocytes Transduced With A Rv-Sfg.cd19.Cd28.4-1Bbzeta Retroviral Vector
Countries:
Germany
Germany- Participants:18–64 years · 65+ years
- Substances:T Lymphocytes Transduced With A Rv-Sfg.cd19.Cd28.4-1Bbzeta Retroviral Vector
- Sponsor:Universitaetsklinikum Heidelberg AöR









